Oncology Institute (DFPH) Long-Term Deferred Tax (2019 - 2020)

Oncology Institute's (DFPH) quarterly Long-Term Deferred Tax came in at $70000.0 in Q3 2020, up 79.49% on a QoQ basis from $39000.0 in Q2 2020.

Oncology Institute (DFPH) Long-Term Deferred Tax (2019 - 2020) Analysis & Trends

Oncology Institute (DFPH) has 2 years of Long-Term Deferred Tax data on file, last reported at $70000.0 in Q3 2020.

Quarterly Long-Term Deferred Tax changed N/A year-over-year to $70000.0 in Q3 2020, while the trailing twelve-month figure through Sep 2020 was $70000.0 (changed N/A YoY) and the FY2019 annual result came in at $25000.0, changed N/A from the prior year.
Long-Term Deferred Tax advanced to $70000.0 in Q3 2020, from $39000.0 in the prior quarter.
In the past five years, Long-Term Deferred Tax ranged from a high of $70000.0 in Q3 2020 to a low of $25000.0 in Q4 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	HCA Healthcare	88.19 Bn	90.61 Bn	15.19 Bn
2	Tenet Healthcare	21.59 Bn	21.56 Bn	4.45 Bn
3	Encompass Health	12.19 Bn	12.86 Bn	1.34 Bn
4	Davita	11.52 Bn	12.39 Bn	1.16 Bn
5	Ensign	10.59 Bn	10.27 Bn	306.24 Mn
6	Universal Health Services	8.79 Bn	8.72 Bn	3.29 Bn
7	Pacs	7.04 Bn	6.88 Bn	338.46 Mn
8	Chemed	6.96 Bn	6.92 Bn	221.47 Mn
9	Concentra Group Holdings Parent	4.52 Bn	4.38 Bn	192.10 Mn
10	Oncology Institute	201.94 Mn	160.85 Mn	27.17 Mn

Download Data